Your session is about to expire
← Back to Search
Exparel for Postoperative Pain
Study Summary
This trial is studying two different pain management interventions for people undergoing reverse shoulder surgery. The primary aim is to compare the two interventions on post-operative opioid consumption, pain scores, and patient satisfaction.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has Exparel received governmental authorization for use?
"With a Phase 4 trial to back it up, Exparel has been given an assurance rating of 3 on our internal scale at Power."
Are there any vacancies available for individuals to participate in this medical experiment?
"Per the information found on clinicaltrials.gov, this medical trial is still open to participants. Initially posted February 5th 2019 and last updated 2/13/2022."
How many individuals are engaging in this investigation?
"Affirmative, according to information on clinicaltrials.gov, the medical research project is looking for participants at this time. The study was initially published on February 5th 2019 and last modified on 2/13/2022; 76 people are required from 1 facility."
Are there any existing precedents of Exparel being utilized in a clinical context?
"Currently, there are 109 clinical trials underway examining the efficacy of Exparel. Of these studies, 18 have advanced to Phase 3 and are conducted in Philadelphia as well as 144 other sites across the nation."
Share this study with friends
Copy Link
Messenger